James V. Cassella, Chief Development Officer at CONCERT PHARMACEUTICALS, INC. (CNCE), sold 2,893 shares at $7.25 ($21K) on 2023-01-06, disclosed to the SEC on 2023-01-09.
Scheduled sale ($21k) by Chief Development Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| CNCE | SELL | 2022-02-16 | $12K | — | Filing → |
| CNCE | SELL | 2022-01-07 | $9K | — | Filing → |
| CNCE | SELL | 2021-08-17 | $27K | — | Filing → |